FDA Authorizes 20 ZYN Nicotine Pouches to Be Marketed with Specific Modified Risk Claim
July 01, 2026 by fda.gov
FDA Authorizes 20 ZYN Nicotine Pouches to Be Marketed with Specific Modified Risk Claim
The FDA’s authorisation of modified risk claims for 20 ZYN nicotine pouch products marks an important step for evidence-based nicotine communication. Adults who smoke should be able to receive clear information that switching completely from cigarettes to authorised smoke-free products can reduce specific disease risks. The decision recognises that not all nicotine products carry the same harm, and that accurate relative-risk messaging can support better choices. Public health should make lower-risk information visible, not harder to say.
July 01, 2026 by reuters.com
FDA allows Philip Morris to market Zyn as less harmful than cigarettes
The FDA’s decision to allow ZYN nicotine pouches to be marketed as less harmful than cigarettes is …
14.10% of the adult population are current smokers. There are approximately 39.8 million current smokers in United States 17.10% of men are current smokers but only 11.10% of women.
SOURCE: GSTHR
